 |
 |
Search
- Page Path
-
- HOME
- Search
- Safety, efficacy, and onset of a novel botulinum toxin type A (Nabota) for the treatment of glabellar frown lines: a single-arm, prospective, phase 4 clinical study
- Sinyoung Song, Yeon Hoon Lee, Joon Pio Hong, Tae Suk Oh
- Arch Craniofac Surg. 2018;19(3):168-174. Published online September 20, 2018
-
Full text 
PubReader 
ePub 
PDF
- ARTICLE CATEGORY
- Editorial Office
-
Dept. of Plastic and Reconstructive Surgery Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Korea
Tel: +82-62-220-6354 Fax: +82-62-220-6357 E-mail: office_acfs@kcpca.or.kr
Copyright © 2024 by Korean Cleft Palate-Craniofacial Association.
